{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:37:41Z","timestamp":1780079861652,"version":"3.54.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022ZD0211800"],"award-info":[{"award-number":["2022ZD0211800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81920108017"],"award-info":[{"award-number":["81920108017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001283"],"award-info":[{"award-number":["82001283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130036"],"award-info":[{"award-number":["82130036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["BE2020620"],"award-info":[{"award-number":["BE2020620"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejphar.2023.176201","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T21:57:09Z","timestamp":1700344629000},"page":"176201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["LLDT-8 ameliorates experimental autoimmune encephalomyelitis by mediating macrophage functions in the priming stage"],"prefix":"10.1016","volume":"962","author":[{"given":"Xiaohong","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lushan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-0319","authenticated-orcid":false,"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176201_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0162-3109(98)00006-X","article-title":"Suppressive effects of Tripterygium wilfordii Hook f., a traditional Chinese medicine, on collagen arthritis in mice","volume":"39","author":"Asano","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejphar.2023.176201_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.tig.2017.09.004","article-title":"The genetics of multiple sclerosis: from 0 to 200 in 50 years","volume":"33","author":"Baranzini","year":"2017","journal-title":"Trends Genet."},{"key":"10.1016\/j.ejphar.2023.176201_bib3","article-title":"(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study","volume":"34","author":"Cao","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ejphar.2023.176201_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbadis.2010.07.008","article-title":"The role of antigen presenting cells in multiple sclerosis","volume":"1812","author":"Chastain","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2023.176201_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jphs.2016.05.003","article-title":"LLDT-8 protects against cerebral ischemia\/reperfusion injury by suppressing post-stroke inflammation","volume":"131","author":"Chen","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2023.176201_bib6","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.ejphar.2023.176201_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jneuroim.2006.03.011","article-title":"(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation","volume":"175","author":"Fu","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2023.176201_bib8","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.7150\/thno.57745","article-title":"Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives","volume":"11","author":"Gao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2023.176201_bib9","doi-asserted-by":"crossref","first-page":"21546","DOI":"10.1073\/pnas.2003339117","article-title":"Immune signatures of prodromal multiple sclerosis in monozygotic twins","volume":"117","author":"Gerdes","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.176201_bib10","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/art.1780351122","article-title":"Suppression of renal disease and arthritis, and prolongation of survival in MRL-lpr mice treated with an extract of Tripterygium wilfordii Hook f","volume":"35","author":"Gu","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2023.176201_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2023.176201_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/j.1939-4640.2000.tb02137.x","article-title":"Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats","volume":"21","author":"Huynh","year":"2000","journal-title":"J. Androl."},{"key":"10.1016\/j.ejphar.2023.176201_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jcp.29833","article-title":"Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12","volume":"236","author":"Jiang","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2023.176201_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2016.08.013","article-title":"Contribution of EAE to understanding and treating multiple sclerosis","volume":"304","author":"Lovett-Racke","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2023.176201_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4939-7837-3_23","article-title":"Depleting macrophages in vivo with clodronate-liposomes","volume":"1784","author":"Moreno","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.176201_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/aps.2017.88","article-title":"(5R)-5-hydroxytriptolide ameliorates anti-glomerular basement membrane glomerulonephritis in NZW mice by regulating Fc\u03b3 receptor signaling","volume":"39","author":"Qi","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.176201_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105678","article-title":"Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB\/c mice via suppressing the IL-36\u03b1 signaling pathway","volume":"169","author":"Qi","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2023.176201_bib18","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/brain\/awab088","article-title":"Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging","volume":"144","author":"Rahmanzadeh","year":"2021","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.ejphar.2023.176201_bib19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1745-7254.2007.00524.x","article-title":"(5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice","volume":"28","author":"Ren","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.176201_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/brain\/awaa381","article-title":"Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis","volume":"144","author":"Schiavi","year":"2021","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.ejphar.2023.176201_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2007.06.013","article-title":"How cells respond to interferons revisited: from early history to current complexity","volume":"18","author":"Stark","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2023.176201_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/aps.2012.108","article-title":"Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8)","volume":"33","author":"Tang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.176201_bib23","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/art.1780341011","article-title":"Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness","volume":"34","author":"Tao","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2023.176201_bib24","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2023.176201_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2012.05.004","article-title":"(5R)-5-hydroxytriptolide (LLDT-8), a novel immunosuppressant in clinical trials, exhibits potent antitumor activity via transcription inhibition","volume":"324","author":"Wang","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2023.176201_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2012.05.004","article-title":"(5R)-5-hydroxytriptolide (LLDT-8), a novel immunosuppressant in clinical trials, exhibits potent antitumor activity via transcription inhibition","volume":"324","author":"Wang","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2023.176201_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.imlet.2020.05.005","article-title":"Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplantation","volume":"225","author":"Xin","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejphar.2023.176201_bib28","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3389\/fphar.2019.01469","article-title":"Application and mechanisms of triptolide in the treatment of inflammatory diseases-A review","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176201_bib29","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/med.21762","article-title":"Tripterygium wilfordii: an inspiring resource for rheumatoid arthritis treatment","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2023.176201_bib30","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1745-7254.2006.00457.x","article-title":"(5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling","volume":"27","author":"Zhou","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.176201_bib31","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.intimp.2005.06.009","article-title":"(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo","volume":"5","author":"Zhou","year":"2005","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2023.176201_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/jpet.105.093179","article-title":"Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages","volume":"316","author":"Zhou","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2023.176201_bib33","article-title":"viaTherapeutic effects of (5r)-5-hydroxytriptolide on fibroblast-like synoviocytes in rheumatoid arthritis lncRNA WAKMAR2\/miR-4478\/E2F1\/p53 Axis","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992300715X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992300715X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:24:34Z","timestamp":1762143874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992300715X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":33,"alternative-id":["S001429992300715X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176201","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LLDT-8 ameliorates experimental autoimmune encephalomyelitis by mediating macrophage functions in the priming stage","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176201"}}